D-0163-2017 Class II Terminated
FDA drug recall D-0163-2017 was initiated by Ascend Laboratories LLC on Nov 2, 2016 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP The recall status is terminated (terminated Jun 7, 2017). Affected quantity: 1739 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 7, 2016
- Initiation Date
- Nov 2, 2016
- Termination Date
- Jun 7, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1739 bottles
Product description
Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Montvale, NJ NDC 67877-217-10
Reason for recall
Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP
Distribution pattern
AL, FL, GA, SC & TN
Code information
Lot 6121056, exp 5/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0163-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026